Immunogenicity and safety of trivalent inactivated influenza vaccine in adults living with HIV compared with HIV-uninfected adults: a study from China
To evaluate the immunogenicity and safety of trivalent inactivated influenza vaccine (IIV3) in adults aged ≥18 years living with HIV and to provide evidence supporting influenza vaccination in this population in China. This single-center, open-label comparative analysis was derived from a larger three-arm cl...